Journal articles on the topic 'USFDA'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'USFDA.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Chahal, Harinder Singh, Peter Capella, Ryan Presto, et al. "Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment." BMJ Global Health 3, no. 3 (2018): e000651. http://dx.doi.org/10.1136/bmjgh-2017-000651.
Full textImran, Mohd, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, et al. "Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades." Pharmaceuticals 14, no. 8 (2021): 710. http://dx.doi.org/10.3390/ph14080710.
Full textYogesh, M. Binnar. "Warning Letter: Cause and Remedy in Pharmaceutical Industry." International Journal in Pharmaceutical Sciences 2, no. 5 (2024): 1069–75. https://doi.org/10.5281/zenodo.11234707.
Full textMeesters, Roland JW, and Stephan Voswinkel. "Bioanalytical Method Development and Validation: from the USFDA 2001 to the USFDA 2018 Guidance for Industry." Journal of Applied Bioanalysis 4, no. 3 (2018): 67–73. http://dx.doi.org/10.17145/jab.18.010.
Full textDr., S. D. Mankar Kalyani Nikam* Vaishnavi Palve Vaishnavi Nirmal Pallavi Palve Jagdish Nikam. "USFDA Guidelines: A review on Pharmaceuticals Formulations." International Journal of Pharmaceutical Sciences 3, no. 4 (2025): 1473–79. https://doi.org/10.5281/zenodo.15201903.
Full textKshatriya, Garima, and Dilip G. Maheshwari. "A Comprehensive and Comparative study of qualification process for Drug Development tools in US, Europe, Japan and India." International Journal of Drug Regulatory Affairs 6, no. 2 (2018): 1–7. http://dx.doi.org/10.22270/ijdra.v6i2.227.
Full textBoyer, Ivan J., Wilma F. Bergfeld, Bart Heldreth, Monice M. Fiume, and Lillian J. Gill. "The Cosmetic Ingredient Review Program—Expert Safety Assessments of Cosmetic Ingredients in an Open Forum." International Journal of Toxicology 36, no. 5_suppl2 (2017): 5S—13S. http://dx.doi.org/10.1177/1091581817717646.
Full textJaiswal, Sandhya, Parshant Sharma, and Heena Qureshi. "A Comparative Study of Regulations of Nasal Products in the US and EU." International Journal of Drug Regulatory Affairs 11, no. 1 (2023): 15–23. http://dx.doi.org/10.22270/ijdra.v11i1.573.
Full textHudu, Shuaibu A., Fayig Elmigdadi, Aiman Al Qtaitat, et al. "Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need." Journal of Clinical Medicine 12, no. 15 (2023): 5114. http://dx.doi.org/10.3390/jcm12155114.
Full textSharma, Akash, Vriti Gamta, and Gaurav Luthra. "Regulatory Compliance in the United States: A Comprehensive Analysis of USFDA Guidelines and Implementation Strategies." Journal of Pharmaceutical Research International 35, no. 17 (2023): 41–50. http://dx.doi.org/10.9734/jpri/2023/v35i177389.
Full textRajendra, Mogal* Madhavi shinde Ashwini Shelke Rahul Sable Anil Jadhav. "APPLICATIONS OF SIMULTANEOUS EQUATION METHOD FOR THE DETERMINATION OF EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TO DISSOLUTION STUDIES IN MARKETED TABLETS." Indo American Journal of Pharmaceutical Sciences 04, no. 10 (2017): 3650–54. https://doi.org/10.5281/zenodo.1035796.
Full textZhang, Chao, Yue Ma, Xiao Yan Zhao, and Fen Wang. "Effect of Drying Treatments on Anthocyanin, Fumonisin B1, Aflatoxin B1 Content of Anthocyanin Extract from Purple Corn (Zea may L.) in North China." Advanced Materials Research 335-336 (September 2011): 1396–401. http://dx.doi.org/10.4028/www.scientific.net/amr.335-336.1396.
Full textAlmutairi, R., V. Sanogo, and K. Diaby. "CO51 Safety Profile of Approved Alzheimer's Medication By USFDA." Value in Health 26, no. 12 (2023): S23. http://dx.doi.org/10.1016/j.jval.2023.09.123.
Full textMunesh, Ganesha, and Madhavi Lakshmi Ratna Bhavaraju. "Regulatory framework for USFDA regulated drug product labeling update." Pharmaceutical Sciences Asia 51, no. 1 (2024): 10–18. http://dx.doi.org/10.29090/psa.2024.01.23.731.
Full textAbhishek, Chakraborty. "A Descriptive Study of the Regulations of Leachable and Extractables of US, Europe and Canada." International Journal of Pharmaceutics & Pharmacology 2, no. 2 (2018): 1–15. https://doi.org/10.31531/2581-3080.1000129.
Full textZhang, Chao, Yue Ma, Xiao Yan Zhao, and Fen Wang. "Effect of Storage Treatments on Anthocyanin, Fumonisin B1, Aflatoxin B1 Content of Anthocyanin Extract from Purple Corn (Zea may L.) in North China." Advanced Materials Research 361-363 (October 2011): 759–63. http://dx.doi.org/10.4028/www.scientific.net/amr.361-363.759.
Full textSatheesh, S., S. Abimanyu, and R. Kamaraj. "Regulatory Challenges of Sterile Formulation Development As Per USFDA Prospectives." Research Journal of Pharmacy and Technology 13, no. 3 (2020): 1511. http://dx.doi.org/10.5958/0974-360x.2020.00275.9.
Full textP. S, Sivaranjani, Priyadharshini S, and Nagalakshmi S. "Navigating Digital Health Technology: A Comprehensive Review of USFDA Regulations." Journal of Advances in Medical and Pharmaceutical Sciences 26, no. 10 (2024): 1–11. http://dx.doi.org/10.9734/jamps/2024/v26i10716.
Full textKumar, T. Sudheer, and Raju Kamaraj. "Compliance challenges in clinical research organizations: A USFDA inspection retrospective." Journal of Pharmacy & Pharmacognosy Research 12, no. 1 (2024): 91–98. http://dx.doi.org/10.56499/jppres23.1782_12.1.91.
Full textManisha, B. Divraniya1 Maitreyi Zaveri2 Zuki Patel*3. "Optimizing RTR (Refuse To Receive) Filing For Enhanced Regulatory Compliance In Pharmaceutical Submission And Briefing The Analysis Of The USFDA ECTD Publishing." International Journal in Pharmaceutical Sciences 2, no. 5 (2024): 1866–72. https://doi.org/10.5281/zenodo.11403389.
Full textAmaravadi, Divya, Sravya Guptha, and Rama Rao Tadikonda. "Pregnancy Related Medication Prescription Patterns." International Journal of Medical Sciences and Pharma Research 10, no. 3 (2024): 1–5. http://dx.doi.org/10.22270/ijmspr.v10i3.101.
Full textChristopher, Devasahayam J., Narmada Ashok, Aruna Ravivarma, et al. "Low Potency of Indian Dust Mite Allergen Skin Prick Test Extracts Compared to FDA-Approved Extracts: A Double-Blinded Randomized Control Trial." Allergy & Rhinology 9 (January 2018): 215265671879674. http://dx.doi.org/10.1177/2152656718796746.
Full textRajueni, Khujith, and Mohua Chakraborty Choudhury. "Assessment of the availability of repurposed orphan drugs in India." PLOS Global Public Health 3, no. 9 (2023): e0001498. http://dx.doi.org/10.1371/journal.pgph.0001498.
Full textMishra, Gaurav, Amisha Thakur, and Sukhbir Kaur. "Process Validation of Metformin Hydrochloride Tablet (500 mg) according to USFDA." Biological Sciences 01, no. 01 (2022): 07–08. http://dx.doi.org/10.55006/biolsciences.2021.1102.
Full textJahangir, MA, SS Imam, I. Kazmi, and A. Muheem. "Type 2 Diabetes Current and Future Medications: A Short Review." International Journal of Pharmaceutics & Pharmacology Volume 1, Issue 1 (2017): 101. https://doi.org/10.5281/zenodo.1156225.
Full textAshara, Kalpesh C., Vishal P. Mendapara, Nitin M. Mori, and J. K. Badjatya. "SUPAC OF IMMEDIATE-RELEASE, MODIFIED- RELEASE AND SEMI-SOLID: A REGULATORY NOTE." International Journal of Drug Regulatory Affairs 2, no. 3 (2018): 52–61. http://dx.doi.org/10.22270/ijdra.v2i3.142.
Full textRajat, Garg Anuj Garg. "DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC METHOD FOR TACROLIMUS IN BULK AND MARKETED GEL." Turkish Journal of Physiotherapy and Rehabilitation 32, no. 3 (2021): 41116–72. https://doi.org/10.5281/zenodo.6973281.
Full textAdhao, Vaibhav S., Jaya P. Ambhore, Anant D. Bhuskat, and Dishali V. Talokar. "Comparative in-Vitro dissolution study of some sitagliptin generic tablets under biowaiver conditions by UV-Spectroscopy." Current Trends in Pharmacy and Pharmaceutical Chemistry 6, no. 3 (2024): 114–21. http://dx.doi.org/10.18231/j.ctppc.2024.025.
Full textAhammad, Nisar, Nagarjuna Reddy, M. V. Nagabhushanam, and Brahmaiah Ramakrishna. "Challenges Faced During eCTD and CTD Filling Procedures for USFDA and Canada." Journal of Drug Delivery and Therapeutics 9, no. 4-s (2019): 673–79. http://dx.doi.org/10.22270/jddt.v9i4-s.3334.
Full textRaguri, Gopi Chand, Koushik Yetukuri, and Rama Rao Nadendla. "Trend Analysis of Anti-Viral Drugs Approved by USFDA during 2019-2023." International Journal of Pharmaceutical Investigation 14, no. 4 (2024): 1174–80. http://dx.doi.org/10.5530/ijpi.14.4.128.
Full textFahmi, A. Suhaeli, Moch Maksum, and Endy Suwondo. "USFDA Import Refusal and Export Competitiveness of Indonesian Crab in US Market." Agriculture and Agricultural Science Procedia 3 (2015): 226–30. http://dx.doi.org/10.1016/j.aaspro.2015.01.044.
Full textShaikh, J., and M. Samnaliev. "HPR22 Real-World Evidence Usage in Regulatory Approvals from USFDA and EMA." Value in Health 26, no. 6 (2023): S215. http://dx.doi.org/10.1016/j.jval.2023.03.1169.
Full textBhanwra, Sangeeta, Sonia S. Mahajan, and Rajiv Kumar. "Lasmiditan: the first neurally acting anti-migraine drug." International Journal of Basic & Clinical Pharmacology 10, no. 6 (2021): 745. http://dx.doi.org/10.18203/2319-2003.ijbcp20212088.
Full textMirza, Mohd A., and Zeenat Iqbal. "3D Printing in Pharmaceuticals: Regulatory Perspective." Current Pharmaceutical Design 24, no. 42 (2019): 5081–83. http://dx.doi.org/10.2174/1381612825666181130163027.
Full textGhosal, Samit, and Binayak Sinha. "Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS." Journal of Diabetes Research 2016 (2016): 1–7. http://dx.doi.org/10.1155/2016/1643496.
Full textChawan, Vihang S., Sagar V. Badwane, Kalpesh V. Gawand, Abhishek M. Phatak, and Madhura S. Naik. "Analysis of randomized clinical trials leading to new drug approvals in India and USA." International Journal of Clinical Trials 3, no. 2 (2016): 68. http://dx.doi.org/10.18203/2349-3259.ijct20161413.
Full textSillankorva, Sanna M., Hugo Oliveira, and Joana Azeredo. "Bacteriophages and Their Role in Food Safety." International Journal of Microbiology 2012 (2012): 1–13. http://dx.doi.org/10.1155/2012/863945.
Full textRaharjo, Tri Joko, Tri Wahyudi, and Sismindari Sismindari. "USFDA-GUIDELINE BASED VALIDATION OF TESTING METHOD FOR RIFAMPICIN IN INDONESIAN SERUM SPECIMEN." Indonesian Journal of Chemistry 10, no. 1 (2010): 138–41. http://dx.doi.org/10.22146/ijc.21494.
Full textBlanchetti-Revelli, Lanfranco. "Keeping Meat and Dairy Consumers Slim: Philippine Seaweed, American Carrageenan and the USFDA." Anthropology Today 13, no. 5 (1997): 6. http://dx.doi.org/10.2307/2783558.
Full textParth, Killedar* Tanuja Khopade Siddhi Kurhade Nutan Kokare Shubhangi Khemnar S. D. Mankar. "Comparative Study of Regulatory Requirements for Drug Approval (USFDA vs. EMA vs. INDIA)." International Journal of Pharmaceutical Sciences 3, no. 4 (2025): 3002–13. https://doi.org/10.5281/zenodo.15276998.
Full textMore, Ghansham S., Asha B. Thomas, Sohan S. Chitlange, Rabindra K. Nanda, and Rahul L. Gajbhiye. "Nitrogen Mustards as Alkylating Agents: A Review on Chemistry, Mechanism of Action and Current USFDA Status of Drugs." Anti-Cancer Agents in Medicinal Chemistry 19, no. 9 (2019): 1080–102. http://dx.doi.org/10.2174/1871520619666190305141458.
Full textde Sousa, Ana Carolina C., Keletso Maepa, Jill M. Combrinck, and Timothy J. Egan. "Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites." Molecules 25, no. 7 (2020): 1571. http://dx.doi.org/10.3390/molecules25071571.
Full textPatel, Jimi, Priti Mehta, and Vaishali Kothari. "COMPARISON OF GLOBAL REGULATORY GUIDELINES FOR AVAILABILITY OF DIFFERENT BIOWAIVER PROVISIONS AND APPLICATION REQUIREMENTS OF BIOPHARMACEUTICS CLASSIFICATION SYSTEM (BCS) BASED BIOWAIVER." International Journal of Drug Regulatory Affairs 3, no. 3 (2018): 8–20. http://dx.doi.org/10.22270/ijdra.v3i3.167.
Full textPooja Chaudhari and Jitendra Kumar Badjatya. "Good Practices in Management of deficiencies in CTD dossier and comparative study for US, EU and Australia." International Journal of Drug Regulatory Affairs 7, no. 4 (2019): 40–55. http://dx.doi.org/10.22270/ijdra.v7i4.371.
Full textJagatp, Sneha R., and Omprakash G. Bhusnure. "A Review on Eight System Inspection Model." Journal of Drug Delivery and Therapeutics 9, no. 4 (2019): 713–19. http://dx.doi.org/10.22270/jddt.v9i4.3140.
Full textShakira, Anam Ilyas, Laiba Anwar, et al. "Computational study on gabapentin as a potential therapy for partial seizures." World Journal of Biology Pharmacy and Health Sciences 12, no. 3 (2022): 025–32. http://dx.doi.org/10.30574/wjbphs.2022.12.3.0204.
Full textShakira, Ilyas Anam, Anwar Laiba, et al. "Computational study on gabapentin as a potential therapy for partial seizures." World Journal of Biology Pharmacy and Health Sciences 12, no. 3 (2022): 025–32. https://doi.org/10.5281/zenodo.7636136.
Full textDePaola, Angelo. "A new wave in oyster farming: Making oysters cheaper than chicken." Open Access Government 46, no. 1 (2025): 396–97. https://doi.org/10.56367/oag-046-11899.
Full textImran, Mohd, Abdulaziz Khalaf Alshammari, Khalid Ramadan Alhamad, et al. "Mavorixafor: A spotlight on the clinical aspects and prospects of the first USFDA-approved treatment for the primary immunodeficiency WHIM syndrome." Advancements in Life Sciences 11, no. 4 (2024): 726. http://dx.doi.org/10.62940/als.v11i4.3504.
Full textChacko, S., S. K Viswam, N. Ravindra Reddy, V. Sharma, and A. Bellapu. "PRS58 MEPOLIZUMAB INDUCED MYALGIA: A DISPROPORTIONALITY ANALYSIS IN USFDA ADVERSE EVENT REPORTING SYSTEM DATABASE." Value in Health 22 (November 2019): S882. http://dx.doi.org/10.1016/j.jval.2019.09.2547.
Full text